Magnesium sulfate (medical use) solution. In the United Kingdom 4 ml of 20% solution costs the NHS about 10.23 pounds. In the United States a course of medication typically costs less than $25. Magnesium sulfate is the primary treatment and preventative measure in women with eclampsia. It lowers systolic blood pressure while maintaining diastolic blood pressure, thus leaving blood flow to the fetus uncompromised. Magnesium sulphate was once used as a tocolytic, but meta-analyses have failed to support it as an anti-contraction medication. Usage for prolonged periods (more than five to seven days) may result in health problems for the baby. In those at
Magnesium hydroxide in 1872 for a suspension of magnesium hydroxide formulated at about 8%w/v. It was sold under the brand name "Phillips' Milk of Magnesia" for medicinal usage. Although the name may at some point have been owned by GlaxoSmithKline, USPTO registrations show "Milk of Magnesia" and "Phillips' Milk of Magnesia" have both been assigned to Bayer since 1995. In the UK, the non-brand (generic) name of "Milk of Magnesia" and "Phillips' Milk of Magnesia" is "Cream of Magnesia" (Magnesium Hydroxide Mixture, BP). It is added directly to human food, and is affirmed as generally recognized as safe by the FDA. It